In CC, FOXD3-AS1 modulates the progression of the tumor through the expression of miR-296-5p targeting HMGA1 [36] or targeting and negatively regulating miR-128-3p, which indirectly up-regulated LIMK1 expression [37]. This evidence concerns the gene FOXD3 and neoplasm.